HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia Esperanza Flores-Martínez Selected Research

Silvia Esperanza Flores-Martínez Research Topics

Disease

4Insulin Resistance
02/2018 - 02/2013
3Obesity
01/2017 - 08/2010
3Type 2 Diabetes Mellitus (MODY)
10/2013 - 08/2010
2Gestational Diabetes (Gestational Diabetes Mellitus)
02/2018 - 02/2013
1Carcinogenesis
08/2021
1Inflammation (Inflammations)
08/2021
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2019
1Colorectal Neoplasms (Colorectal Cancer)
11/2019
1Drug-Related Side Effects and Adverse Reactions
11/2016
1Hyperinsulinism (Hyperinsulinemia)
10/2013
1Epilepsy (Aura)
05/2013
1Seizures (Absence Seizure)
05/2013
1Cardiovascular Diseases (Cardiovascular Disease)
08/2010
1Overweight
08/2010

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
11/2019 - 02/2018
2Insulin (Novolin)FDA Link
02/2018 - 02/2013
2Genetic Markers (Genetic Marker)IBA
01/2017 - 08/2010
2Interleukin-6 (Interleukin 6)IBA
10/2013 - 08/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2013 - 01/2011
1MAP Kinase Kinase 4IBA
08/2021
1CateninsIBA
11/2019
1DNA (Deoxyribonucleic Acid)IBA
11/2019
1calpain 10IBA
02/2018
1Glucose (Dextrose)FDA LinkGeneric
02/2018
1Therapeutic UsesIBA
11/2016
1Cytochrome P-450 CYP2C19IBA
11/2016
1Cytochrome P-450 CYP2C9IBA
11/2016
1Plasminogen Activator Inhibitor 1IBA
09/2013
1Plasminogen Activators (Plasminogen Activator)IBA
09/2013
1Anticonvulsants (Antiepileptic Drugs)IBA
05/2013
1CytokinesIBA
02/2013